Why Kailera Therapeutics, Inc. (KLRA) stock rose 5.2% intraday on Tuesday, November 10, 2026
Kailera Therapeutics, Inc. (KLRA) traded at $14.42 as of 10:31 AM ET, up 5.22% on Tuesday, November 10, 2026, on volume of 244,989 shares (0.2× its 3-month average); market value about $1.90B.
KLRA was among the stocks moving 5% or more in an earlier update that day; as of 11:31 AM ET it was no longer moving that much.
What happened: primary sources
Events Nexqual found for KLRA on Tuesday, November 10, 2026 or the trading day before (November 9, 2026):
- Nov 9, 2026: Canaccord Genuity: Initiated, Buy, price target $44
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on KLRA
KLRA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 10, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:32 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:32 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt